Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share (LBRX).
- Disclosed ownership: 8.7%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 8.7% ownership in LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share (LBRX) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 8.7% | 2,208,604 | 0 | 2,208,604 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 8.7% | 2,208,604 | 0 | 2,208,604 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 8.7% | 2,208,604 | 0 | 2,208,604 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 8.7% | 2,208,604 | 0 | 2,208,604 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |